Clinical Trial Update: A Long-Term Monitoring Study of the IMT-002 Patients [NA]

View source ↗

Summary

This update reports long-term monitoring outcomes for patients treated with IMT-002 for age-related macular degeneration, and the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• IMT-002

Snippet

Sponsor: VisionCare, Inc. | Conditions: Macular Degeneration | NA | Status: COMPLETED